The store will not work correctly when cookies are disabled.
2-(5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)ethyl carbamimidothioate
ID: ALA1806660
PubChem CID: 53375910
Max Phase: Preclinical
Molecular Formula: C15H12N4O4S
Molecular Weight: 344.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)SCCN1C(=O)c2cccc3cc([N+](=O)[O-])cc(c23)C1=O
Standard InChI: InChI=1S/C15H12N4O4S/c16-15(17)24-5-4-18-13(20)10-3-1-2-8-6-9(19(22)23)7-11(12(8)10)14(18)21/h1-3,6-7H,4-5H2,(H3,16,17)
Standard InChI Key: OOBGVUOHGJKFSU-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
13.1226 -3.5913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1214 -4.4187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8344 -3.1787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8354 -4.8293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8338 -5.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5487 -6.0687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2667 -5.6526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5497 -3.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5485 -4.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2654 -4.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9880 -4.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9892 -3.5898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2678 -3.1700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2678 -2.3450 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7013 -4.8373 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7046 -3.1791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4180 -3.5933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1334 -3.1826 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.8468 -3.5968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5622 -3.1861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.8448 -4.4218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5509 -6.8983 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2653 -7.3109 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8365 -7.3107 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8 13 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 1 0
5 6 1 0
13 14 2 0
8 3 2 0
11 15 2 0
6 7 2 0
12 16 1 0
7 10 1 0
16 17 1 0
8 9 1 0
17 18 1 0
3 1 1 0
18 19 1 0
1 2 2 0
19 20 1 0
9 4 1 0
19 21 2 0
2 4 1 0
4 5 2 0
22 23 2 0
22 24 1 0
6 22 1 0
M CHG 2 22 1 24 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 344.35 | Molecular Weight (Monoisotopic): 344.0579 | AlogP: 1.97 | #Rotatable Bonds: 4 |
Polar Surface Area: 130.39 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.57 | CX LogP: 1.83 | CX LogD: -0.52 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.29 | Np Likeness Score: -1.09 |
References
1. Sk UH, Prakasha Gowda AS, Crampsie MA, Yun JK, Spratt TE, Amin S, Sharma AK.. (2011) Development of novel naphthalimide derivatives and their evaluation as potential melanoma therapeutics., 46 (8): [PMID:21609852] [10.1016/j.ejmech.2011.04.058] |